Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Combined associations of family history and self-management with age at diagnosis and cardiometabolic risk in 86,931 patients with type 2 diabetes: Joint Asia Diabetes Evaluation (JADE) Register from 11 countries

Fig. 2

Kaplan-Meier estimate of age at diagnosis stratified by presence of family history. FamH, family history of diabetes (father, mother, and/or siblings). The figure shows the mean age at diagnosis (years) in non-FamH group vs. FamH group in (A) overall study population [52.5, 95%CI 52.4–52.6] vs. [47.9, 95%CI 47.8–49.0], (B) China [53.7, 95%CI 53.3–54.1] vs. [49.6, 95%CI 49.2–50.0], (C) Hong Kong [54.6, 95%CI 54.3–54.8] vs. [49.0, 95%CI 48.8–49.2], (D) India [48.6, 95%CI 48.4–48.7] vs. [45.7, 95%CI 45.6–45.8], (E) Indonesia [53.6, 95%CI 52.7–54.6] vs. [49.8, 95%CI 49.2–50.5], (F) Korea [51.9, 95%CI 51.1–52.7] vs. [48.2, 95%CI 47.5–48.9], (G) Malaysia [53.4, 95%CI 51.9–55.0] vs. [47.9, 95%CI 47.3–48.6], (H) Philippines [55.3, 95%CI 54.9–55.6] vs. [49.7, 95%CI 49.4–50.0], (I) Singapore [53.1, 95%CI 51.3–54.8] vs. [46.9, 95%CI 45.7–48.0], (J) Taiwan [54.3, 95%CI 53.6–54.9] vs. [50.3, 95%CI 49.9–50.8], (K) Thailand [51.5, 95%CI 50.6–52.3] vs. [48.6, 95%CI 47.5–49.6], and (L) Vietnam [54.9, 95%CI 54.6–55.3] vs. [49.8, 95%CI 49.4–50.2]. All comparisons showed p<0.001 with log-rank test

Back to article page